AI-Platform to Tackle Cancer on a Genetic Level

November 22, 2024

We’re building an AI-powered platform to tackle cancer on a genetic level.

What does the platform do?

1. Performs analyse of a person’s genetic code.

2. Identifies mutations in the genetic code.

3. Explores ways to suppress these gene mutations.

The process is powered by AI. Our data is based on renowned publications and is updated daily.

Through this process, we can understand which mutations lead to specific diseases and, accordingly, identify which medications or off-label drugs could help suppress the mutation, enabling the person to recover.

This platform, based on our profound expertise in the field of oncology backed up by AI, is an innovative way to address the problem at its root.

Exosomes Digest (July/2026)

Highlights of the Month The most robust signal is the emergence of data on comparable functional

Exosomes Digest (June/2026)

June 2026 showed that the field of exosomes and extracellular vesicles is gradually shifting from broad

We’ve successfully passed the ISO 9001 Surveillance Audit

Quality means more to us than just a standard – it is an integral part of